Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Medical Journal of Cell Biology
Volume 9 (2021): Numero 3 (September 2021)
Accesso libero
Mesenchymal stem cells and their secretome - candidates for safe and effective therapy for systemic lupus erythematosus
Małgorzata Popis
Małgorzata Popis
,
Aneta Konwerska
Aneta Konwerska
,
Małgorzata Partyka
Małgorzata Partyka
,
Maria Wieczorkiewicz
Maria Wieczorkiewicz
,
Sylwia Ciesiółka
Sylwia Ciesiółka
,
Katarzyna Stefańska
Katarzyna Stefańska
,
Julia Spaczyńska
Julia Spaczyńska
,
Afsaneh Golkar-Narenji
Afsaneh Golkar-Narenji
,
Michal Jeseta
Michal Jeseta
,
Dorota Bukowska
Dorota Bukowska
,
Paul Mozdziak
Paul Mozdziak
e
Marta Dyszkiewicz-Konwińska
Marta Dyszkiewicz-Konwińska
| 27 set 2021
Medical Journal of Cell Biology
Volume 9 (2021): Numero 3 (September 2021)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Articolo
Immagini e tabelle
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
27 set 2021
Pagine:
110 - 122
Ricevuto:
02 ago 2021
Accettato:
05 set 2021
DOI:
https://doi.org/10.2478/acb-2021-0016
Parole chiave
mesenchymal stem cells
,
secretome
,
conditioned media
,
exosomes
,
SLE
© 2021 Małgorzata Popis et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
FIGURE 1
Identification of MSCs is based on following criteria, proposed and recommended by International Society for Cellular Therapy: a) cells must be plastic adherent during culture in standard conditions b) cells must exhibit presence of following markers: CD105, CD73, CD90 and reveal lack expression of following markers: CD45, CD34, HLA-DR, CD14 or CD11b, CD79a or CD19 c) cells must demonstrate the ability toward differentiation to adipocytes, chondroblasts, osteocytes upon culture in standard in vitro differentiating conditions. Created with BioRender.com
FIGURE 2
Mesenchymal stem cell sources can be split into adult tissues like adipose tissue, peripheral blood, ligamentum flavum, annulus fibrosus, bone marrow, or dental pulp, and perinatal tissues including amniotic membrane, amniotic fluid, placenta, umbilical cord Wharton's jelly and umbilical blood. Created with BioRender.com
FIGURE 3
Schematic representation of exosome biogenesis. Process of exosome formation begins with endocytosis, leading to formation of early endosome. Then molecules such as nucleic acids, proteins and lipids, of both intra and extra-cellular origin, invaginate into the lumen of late endosome, giving rise to intraluminal vesicles. Late endosome transform into multivesicular body, which is capable to undergo fusion with cell membrane and release of exosomes to the extracellular space. Created with BioRender.com